Regeneron Pharmaceuticals Stock Performance

REGN Stock  USD 962.49  3.81  0.39%   
Regeneron Pharmaceuticals has a performance score of 9 on a scale of 0 to 100. The company holds a Beta of 0.57, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Regeneron Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Regeneron Pharmaceuticals is expected to be smaller as well. Regeneron Pharmaceuticals right now holds a risk of 0.88%. Please check Regeneron Pharmaceuticals downside variance, and the relationship between the sortino ratio and accumulation distribution , to decide if Regeneron Pharmaceuticals will be following its historical price patterns.

Risk-Adjusted Performance

9 of 100

 
Low
 
High
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Regeneron Pharmaceuticals are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain technical and fundamental indicators, Regeneron Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in April 2024. ...more

Actual Historical Performance (%)

One Day Return
(0.39)
Five Day Return
(1.08)
Year To Date Return
6.35
Ten Year Return
220.53
All Time Return
4.5 K
1
Dremio All In With Achievements Driving Customer Value in 2024 and Beyond
03/05/2024
2
High School Seniors Win 1.8 Million at Regeneron Science Talent Search 2024 for Innovative Scientific Research on Artificial Intelligence, Cancer Metabolism and...
03/13/2024
3
US appeals court revives Regenerons antitrust lawsuit against Novartis
03/18/2024
4
STAT Pharmalittle Were reading about an AstraZeneca deal, a WHO pandemic pact, and more
03/19/2024
5
BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer
03/20/2024
6
Chronic Rhinosinusitis without Nasal Polyps Market to Grow Rapidly by 2032, Predicts DelveInsight
03/21/2024
7
EU adviser says Illumina merger was not problematic
03/22/2024
8
FDA rejects Regeneron lymphoma drug, setting back companys oncology push
03/25/2024
9
Checkpoint Inhibitor Refractory Cancer Market 2032 Epidemiology, Treatment, FDA Approvals, Companies by DelveInsight
03/26/2024
10
Latest Global Cancer Immunotherapy Market SizeShare Worth USD 314.4 Billion by 2032 at a 7.2 percent CAGR Custom Market Insights
03/28/2024
Begin Period Cash Flow3.1 B
  

Regeneron Pharmaceuticals Relative Risk vs. Return Landscape

If you would invest  90,500  in Regeneron Pharmaceuticals on December 30, 2023 and sell it today you would earn a total of  5,749  from holding Regeneron Pharmaceuticals or generate 6.35% return on investment over 90 days. Regeneron Pharmaceuticals is currently generating 0.1049% in daily expected returns and assumes 0.8849% risk (volatility on return distribution) over the 90 days horizon. In different words, 7% of stocks are less volatile than Regeneron, and 98% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Regeneron Pharmaceuticals is expected to generate 1.33 times less return on investment than the market. In addition to that, the company is 1.54 times more volatile than its market benchmark. It trades about 0.12 of its total potential returns per unit of risk. The NYSE Composite is currently generating roughly 0.24 per unit of volatility.

Regeneron Pharmaceuticals Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Regeneron Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Regeneron Pharmaceuticals, and traders can use it to determine the average amount a Regeneron Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.1185

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashREGNAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 0.88
  actual daily
7
93% of assets are more volatile

Expected Return

 0.1
  actual daily
1
99% of assets have higher returns

Risk-Adjusted Return

 0.12
  actual daily
9
91% of assets perform better
Based on monthly moving average Regeneron Pharmaceuticals is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Regeneron Pharmaceuticals by adding it to a well-diversified portfolio.

Regeneron Pharmaceuticals Fundamentals Growth

Regeneron Stock prices reflect investors' perceptions of the future prospects and financial health of Regeneron Pharmaceuticals, and Regeneron Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Regeneron Stock performance.

About Regeneron Pharmaceuticals Performance

To evaluate Regeneron Pharmaceuticals Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Regeneron Pharmaceuticals generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Regeneron Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Regeneron Pharmaceuticals market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Regeneron's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2024
Return On Capital Employed 0.14  0.14 
Return On Assets 0.12  0.13 
Return On Equity 0.15  0.16 

Things to note about Regeneron Pharmaceuticals performance evaluation

Checking the ongoing alerts about Regeneron Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Regeneron Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Regeneron Pharmaceuticals is unlikely to experience financial distress in the next 2 years
Over 89.0% of the company shares are owned by institutional investors
Latest headline from finance.yahoo.com: Latest Global Cancer Immunotherapy Market SizeShare Worth USD 314.4 Billion by 2032 at a 7.2 percent CAGR Custom Market Insights
Evaluating Regeneron Pharmaceuticals' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Regeneron Pharmaceuticals' stock performance include:
  • Analyzing Regeneron Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Regeneron Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
  • Examining Regeneron Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Regeneron Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Regeneron Pharmaceuticals' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Regeneron Pharmaceuticals' stock. These opinions can provide insight into Regeneron Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Regeneron Pharmaceuticals' stock performance is not an exact science, and many factors can impact Regeneron Pharmaceuticals' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
When determining whether Regeneron Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Regeneron Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Regeneron Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Regeneron Pharmaceuticals Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Regeneron Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
To learn how to invest in Regeneron Stock, please use our How to Invest in Regeneron Pharmaceuticals guide.
Note that the Regeneron Pharmaceuticals information on this page should be used as a complementary analysis to other Regeneron Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Complementary Tools for Regeneron Stock analysis

When running Regeneron Pharmaceuticals' price analysis, check to measure Regeneron Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regeneron Pharmaceuticals is operating at the current time. Most of Regeneron Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Regeneron Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regeneron Pharmaceuticals' price. Additionally, you may evaluate how the addition of Regeneron Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Transaction History
View history of all your transactions and understand their impact on performance
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Is Regeneron Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Regeneron Pharmaceuticals. If investors know Regeneron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Regeneron Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.03)
Earnings Share
34.81
Revenue Per Share
122.935
Quarterly Revenue Growth
0.006
Return On Assets
0.0849
The market value of Regeneron Pharmaceuticals is measured differently than its book value, which is the value of Regeneron that is recorded on the company's balance sheet. Investors also form their own opinion of Regeneron Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Regeneron Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Regeneron Pharmaceuticals' market value can be influenced by many factors that don't directly affect Regeneron Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Regeneron Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Regeneron Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Regeneron Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.